460 — Sihuan Pharmaceutical Holdings Share Price
0.000.00%
Last trade - 00:00- HK$6.39bn
- HK$3.91bn
- CNY1.90bn
- 20
- 33
- 71
- 35
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | 5.32% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.31 | ||
| Price to Tang. Book | 1.63 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.02 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.91% | ||
| Return on Equity | -4.92% | ||
| Operating Margin | -7.27% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 2,464.23 | 3,038.39 | 2,181.19 | 1,860.54 | 1,901.11 | 2,514 | n/a | -7.96% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +15.49 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company primarily engaged in the research and development, manufacture and sale of pharmaceutical products and aesthetic products. The Company operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The Company conducts its business in the domestic and overseas markets.
Directors
- Fengsheng Che CHM (59)
- Weicheng Guo CEO (57)
- Yiau Chong Choi CFO (47)
- Jionglong Zhang CIN (59)
- Yanling Chen EDR (43)
- Ming Wai Mok SEC
- Patrick Sun NID (62)
- Wah Kwong Tsang NID (68)
- Xun Zhu NID (63)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 26th, 2006
- Public Since
- October 28th, 2010
- No. of Employees
- 2,667
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 9,264,999,206
- Address
- 21/F, Building 2,Zhbng 2000 Bsns Ctr, BEIJING, 100025
- Web
- https://www.sihuanpharm.com/
- Phone
- +86 75588609726
- Auditors
- Ernst & Young
Upcoming Events for 460
Similar to 460
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Sihuan Pharmaceutical Holdings share price?
As of Today at 23:14 UTC, shares in Sihuan Pharmaceutical Holdings are trading at HK$0.66. This share price information is delayed by 15 minutes.
How has the Sihuan Pharmaceutical Holdings share price performed this year?
Shares in Sihuan Pharmaceutical Holdings last closed at HK$0.66 and the price had moved by +22.22% over the past 365 days. In terms of relative price strength the Sihuan Pharmaceutical Holdings share price has outperformed the FTSE Developed Asia Pacific Index by +23.62% over the past year.
What are the analyst and broker recommendations for Sihuan Pharmaceutical Holdings?
The overall consensus recommendation for Sihuan Pharmaceutical Holdings is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Sihuan Pharmaceutical Holdings dividend yield?
The Sihuan Pharmaceutical Holdings dividend yield is 3.18% based on the trailing twelve month period.
Does Sihuan Pharmaceutical Holdings pay a dividend?
Last year, Sihuan Pharmaceutical Holdings paid a total dividend of CNY0.02, and it currently has a trailing dividend yield of 3.18%. We do not have any data on when Sihuan Pharmaceutical Holdings is to next pay dividends.
When does Sihuan Pharmaceutical Holdings next pay dividends?
We do not have data on when Sihuan Pharmaceutical Holdings is to next pay dividends. The historic dividend yield on Sihuan Pharmaceutical Holdings shares is currently 3.18%.
How do I buy Sihuan Pharmaceutical Holdings shares?
To buy shares in Sihuan Pharmaceutical Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sihuan Pharmaceutical Holdings?
As of the previous close price of HK$0.66, shares in Sihuan Pharmaceutical Holdings had a market capitalisation of HK$6.39bn.
Where are Sihuan Pharmaceutical Holdings shares listed?
Here are the trading details for Sihuan Pharmaceutical Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 460
What kind of share is Sihuan Pharmaceutical Holdings?
Based on an overall assessment of its quality, value and momentum Sihuan Pharmaceutical Holdings is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sihuan Pharmaceutical Holdings share price forecast for 2025?
The analyst consensus target price for shares in Sihuan Pharmaceutical Holdings is HK$2.53. That is 282.62% above the last closing price of HK$0.66.
Analysts covering Sihuan Pharmaceutical Holdings currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Sihuan Pharmaceutical Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sihuan Pharmaceutical Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -1.5%.
As of the last closing price of HK$0.66, shares in Sihuan Pharmaceutical Holdings were trading +7.35% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sihuan Pharmaceutical Holdings PE Ratio?
The Sihuan Pharmaceutical Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.66.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sihuan Pharmaceutical Holdings?
Sihuan Pharmaceutical Holdings' management team is headed by:
- Fengsheng Che - CHM
- Weicheng Guo - CEO
- Yiau Chong Choi - CFO
- Jionglong Zhang - CIN
- Yanling Chen - EDR
- Ming Wai Mok - SEC
- Patrick Sun - NID
- Wah Kwong Tsang - NID
- Xun Zhu - NID